Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,444.25
(
0.58%
)
US TECH 100
28,717.20
(
1.51%
)
Dow Jones
49,693.20
(
-0.14%
)
Brent Oil
103.84
(
0.14%
)
Bitcoin
79,305.94
(
0.03%
)
News Focus
News Focus
Post# of 257556
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Bickema

Send PM Follow Ignore
Followers 19
Posts 1632
Boards Moderated 0
Alias Born 11/10/2010

Bickema

Re: DewDiligence post# 209654

Tuesday, 03/07/2017 9:30:09 AM

Tuesday, March 07, 2017 9:30:09 AM

Post# of 257556
RVNC - Revance Completes Enrollment in Phase 3 Pivotal Trials of RT002 Injectable for the Treatment of Glabellar (Frown) Lines

http://investors.revance.com/releasedetail.cfm?ReleaseID=1016225
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now